Implantable System for Remodulin FDA Approved to Treat Pulmonary Hypertension

Medtronic won FDA approval for its Implantable System for Remodulin (ISR) as a new treatment option for people with pulmonary arterial hypertension. It consists of Medtronic’s Synchromed II drug delivery system, an intravascular catheter, and United Therapeutics‘ Remodulin (treprostinil) Injection medication.

Unlike external infusion p (Read more...)

Full Story →